Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.66 |
| ▸ | CA2 | P00918 | 13/20 | 0.66 |
| ▸ | CA9 | Q16790 | 13/20 | 0.66 |
| ▸ | CA12 | O43570 | 6/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.63 |
| ▸ | CA7 | P43166 | 1/20 | 0.63 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.62 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.55 |
| ▸ | BTK | Q06187 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18737217 | 0.96 | CA9 (0.65) | CA1CA2CA9CA12CA14 | |
| SCHEMBL18737255 | 0.90 | CA9 (0.67) | CA1CA2CA9CA12CA14 | |
| SCHEMBL18736932 | 0.89 | CA9 (0.66) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19426705 | 0.89 | CA9 (0.71) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13219607 | 0.88 | CA1 (0.72) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13815114 | 0.87 | CA1 (0.71) | CA1CA2CA9CA12CA14 | |
| SCHEMBL21183302 | 0.87 | CA9 (0.61) | CA1CA2CA9CA12CA14 | |
| SCHEMBL12185092 | 0.87 | CA9 (0.73) | CA1CA2CA9CA12CA14 | |
| SCHEMBL12160082 | 0.87 | CA1 (0.68) | CA1CA2CA9CA12CA14 | |
| SCHEMBL23118896 | 0.87 | CA9 (0.55) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200214981-A1 | FUNCTIONAL NANOSTRUCTURE | RIKEN (JP) | 2020-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200214981-A1 | FUNCTIONAL NANOSTRUCTURE | LRBA, FABP4, MTDH | CA1 707/4885CA2 2633/4885CA9 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.